FDA Requests Adult Antidepressant Suicidality Data

The agency's review of adult suicidality data will take at least a year to complete, FDA says in a Public Health Advisory. Manufacturers of antidepressants are being asked to review all placebo-controlled trials in adult patients using methodology similar to that used to analyze suicidality in pediatric trials.